Ross Zeitlin

527 total citations
9 papers, 428 citations indexed

About

Ross Zeitlin is a scholar working on Pharmacology, Physiology and Molecular Biology. According to data from OpenAlex, Ross Zeitlin has authored 9 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in Ross Zeitlin's work include Cholinesterase and Neurodegenerative Diseases (5 papers), Alzheimer's disease research and treatments (5 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). Ross Zeitlin is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (5 papers), Alzheimer's disease research and treatments (5 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). Ross Zeitlin collaborates with scholars based in United States, Japan and United Kingdom. Ross Zeitlin's co-authors include Valentina Echeverrı́a, Sarah Burgess, Gary W. Arendash, John S. Dennis, Bruce A. Citron, Joyonna Gamble‐George, Xiangmei Lin, Chuanhai Cao, Sagar P. Patel and John C. Tran and has published in prestigious journals such as Brain Research, Neuroscience and Behavioural Brain Research.

In The Last Decade

Ross Zeitlin

9 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ross Zeitlin United States	7	239	140	106	79	63	9	428
Christina Unger Lithner Sweden	16	266 1.1×	259 1.9×	140 1.3×	151 1.9×	70 1.1×	26	537
Nadine Crouzin France	11	124 0.5×	151 1.1×	124 1.2×	48 0.6×	61 1.0×	16	414
Debora Monteleone Italy	11	185 0.8×	296 2.1×	57 0.5×	109 1.4×	71 1.1×	12	487
Roger Lefort United States	10	227 0.9×	318 2.3×	164 1.5×	89 1.1×	105 1.7×	11	552
Sandra Colié France	10	262 1.1×	165 1.2×	88 0.8×	45 0.6×	71 1.1×	12	495
Nancy Bartolotti United States	6	133 0.6×	147 1.1×	102 1.0×	43 0.5×	83 1.3×	6	359
Michiko Sekiya Japan	12	204 0.9×	274 2.0×	120 1.1×	70 0.9×	97 1.5×	20	490
Andrés Jiménez Spain	14	287 1.2×	105 0.8×	238 2.2×	77 1.0×	74 1.2×	25	652
Gladys L. Caldeira Portugal	7	224 0.9×	127 0.9×	112 1.1×	39 0.5×	43 0.7×	9	435
Deog-Young Choi South Korea	8	214 0.9×	100 0.7×	139 1.3×	72 0.9×	32 0.5×	9	447

Countries citing papers authored by Ross Zeitlin

Since Specialization

Citations

This map shows the geographic impact of Ross Zeitlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Zeitlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Zeitlin more than expected).

Fields of papers citing papers by Ross Zeitlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Zeitlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Zeitlin. The network helps show where Ross Zeitlin may publish in the future.

Co-authorship network of co-authors of Ross Zeitlin

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Zeitlin. A scholar is included among the top collaborators of Ross Zeitlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Zeitlin. Ross Zeitlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Patel, Sagar P., J. Alex Grizzell, Ross Zeitlin, et al.. (2014). Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice. Frontiers in Aging Neuroscience. 6. 162–162. 26 indexed citations

Echeverrı́a, Valentina & Ross Zeitlin. (2012). Cotinine: A Potential New Therapeutic Agent against Alzheimer's disease. CNS Neuroscience & Therapeutics. 18(7). 517–523. 59 indexed citations

Echeverrı́a, Valentina, Ross Zeitlin, Sarah Burgess, et al.. (2011). Cotinine Reduces Amyloid-β Aggregation and Improves Memory in Alzheimer's Disease Mice. Journal of Alzheimer s Disease. 24(4). 817–835. 74 indexed citations

Zeitlin, Ross, et al.. (2011). Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice. Brain Research. 1417. 127–136. 66 indexed citations

Zeitlin, Ross, et al.. (2011). Cotinine enhances the extinction of contextual fear memory and reduces anxiety after fear conditioning. Behavioural Brain Research. 228(2). 284–293. 38 indexed citations

Echeverrı́a, Valentina, Sarah Burgess, Ross Zeitlin, et al.. (2010). P3‐290: Cotinine: A dual‐action drug with multiple benefits against Alzheimer's disease. Alzheimer s & Dementia. 6(4S_Part_17). 1 indexed citations

Echeverrı́a, Valentina, Sarah Burgess, Joyonna Gamble‐George, et al.. (2009). Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice. Neuroscience. 162(4). 1220–1231. 62 indexed citations

Citron, Bruce A., John S. Dennis, Ross Zeitlin, & Valentina Echeverrı́a. (2008). Transcription factor Sp1 dysregulation in Alzheimer's disease. Journal of Neuroscience Research. 86(11). 2499–2504. 96 indexed citations

Burgess, Sarah, Ross Zeitlin, Joyonna Gamble‐George, & Valentina Echeverrı́a. (2008). P2‐319: Cotinine is neuroprotective against beta‐amyloid toxicity. Alzheimer s & Dementia. 4(4S_Part_14). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact